Freda Lewis-Hall

Freda C.
Lewis-Hall was the founder of CDT Equity, Inc., founded in 2021, serving as Independent Non-Executive Chairman from 2023 to 2026.
Current jobs include Chairman-Cures Acceleration Network Review Board at National Center for Advancing Translational Sciences; Director at American Heart Association, Inc., FasterCures, Foundation for the National Institutes of Health, Inc., American Psychiatric Foundation, Harvard Medical School, SpringWorks Therapeutics LLC; Director-Drug Discovery, Development & Translation at National Academy of Medicine (United States) since 2015; Independent Director at Cybin, Inc. starting 2026; Director at Morris Associates, Inc. (Michigan) since 2019; Independent Director at Pyxis Oncology, Inc. since 2021; Fellow at The Royal College of Physicians; Venture Partner at Catalio Capital Management LP; Member-Governors Board at Patient-Centered Outcomes Research Institute since 2010.
Former jobs include Chairman at National Minority Supplier Development Council, Inc.; Vice Chairman & Associate Professor at Howard University College of Medicine; Independent Director at Tenet Healthcare Corp.
(2014–2017), 1Life Healthcare, Inc. (2019–2023), Springworks Therapeutics, Inc. (2017–2025), EXACT Sciences Corp.
(2020–2024); Director at Society For Women's Health Research; Director at LifeHealthCare, Inc. (2019–2023); Senior VP-US Pharmaceuticals & Medical Affairs at Bristol Myers Squibb Co. (2003–2008); Principal at Eli Lilly & Co. (1994–2002); Chief Patient Officer & Executive Vice President at Pfizer Inc. (2019–2020); Chief Medical Officer & EVP-Medicines Development at Vertex Pharmaceuticals, Inc. (2008–2009); Vice President-Product, Research & Development at Pharmacia Corp.
(2002–2003); Trustee at Save The Children Federation Inc.; Principal at National Institute of Mental Health.
Education includes undergraduate degree from The Johns Hopkins University in 1976 and doctorate from Howard University College of Medicine in 1980.